N@N

ALN, ALIM, CELGZ, NPTN, COR, IRIX Are Seasonally Ripe To Go Up In the Next Five Weeks

December 28, 2016 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net is monitoring the Seasonality of American Lorain Corp (NYSE:ALN), Alimera Sciences Inc. (NASDAQ:ALIM), Celgene Corporation (NASDAQ:CELGZ), NeoPhotonics Corporation (NYSE:NPTN), CoreSite Realty Corporation (NYSE:COR), IRIDEX Corporation (NASDAQ:IRIX) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. buyins.net is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:

The following stocks are expected to go Up:

  Symbol  Company                          Expected Return  Odds                 By The Following Date
  ALN     American Lorain Corp             8.97%            87.50% (7 of 8)      Wednesday, January 4th 2017
  ALIM    Alimera Sciences Inc.            3.02%            100.00% (6 of 6)     Monday, January 2nd 2017
  CELGZ   Celgene Corporation              14.11%           100.00% (6 of 6)     Friday, January 6th 2017
  NPTN    NeoPhotonics Corporation         2.08%            100.00% (5 of 5)     Thursday, December 29th 2016
  COR     CoreSite Realty Corporation      7.70%            100.00% (6 of 6)     Thursday, January 19th 2017
  IRIX    IRIDEX Corporation               7.79%            95.00% (19 of 20)    Friday, January 13th 2017

American Lorain Corp (NYSE:ALN) - American Lorain Corporation, through its subsidiaries, develops, manufactures, and sells various food products in the People s Republic of China. It offers chestnut products, including frozen chestnuts and aerated open-bottom chestnuts; and frozen food products, such as frozen vegetables and frozen fruits The company also provides convenience foods comprising ready-to-cook food products, ready-to-eat food products, and meals ready-to- eat products consisting of meal kits with self-heating devices or microwavable kits, such as microwavable rice boxes for military use, as well as for camping, traveling, and other occasions. The company markets and sells its products to supermarket chains, mass merchandisers, wholesalers, and others, as well as to third-party distributors. It also exports its products to the Asia Pacific, Europe, the Middle East, and North America. The company was formerly known as Millennium Quest, Inc. American Lorain Corporation is headquartered in Junan County, the People s Republic of China..

Alimera Sciences Inc. (NASDAQ:ALIM) - Alimera Sciences, Inc., a pharmaceutical company, engages in the research, development, and commercialization of prescription ophthalmic pharmaceuticals in the United States, Germany, Portugal, and the United Kingdom. The company focuses on diseases affecting the back of the eye or retina. The company offers ILUVIEN, an intravitreal implant for the treatment of diabetic macular edema (DME), which is a disease of the retina that affects individuals with diabetes and can lead to severe vision loss and blindness. Its ILUVIEN is inserted in the back of the patient s eye in a non-surgical procedure, which allows for a self-sealing wound by delivering a constant micro-dose of the non-proprietary corticosteroid fluocinolone acetonide in the eye. It has license agreement with pSivida US, Inc. for the development and sale of ILUVIEN, and a delivery device to deliver other corticosteroids to the back of the eye for the treatment and prevention of eye diseases in humans (other than uveitis) or to treat DME. Alimera Sciences, Inc. was founded in 2003 and is headquartered in Alpharetta, Georgia..

Celgene Corporation (NASDAQ:CELGZ) - Celgene Corporation discovers, develops, and commercializes innovative therapies to treat cancer and immune-inflammatory diseases in the United States, Europe, and internationally. Its commercial stage products include REVLIMID for the treatment in combination with dexamethasone for multiple myeloma patients, as well as patients with transfusion-dependent anemia; and THALOMID to treat, in combination with dexamethasone, patients with newly diagnosed multiple myeloma, as well as for the prevention and suppression of cutaneous manifestations of erythema nodosum leprosum recurrence. The company also sells VIDAZA, used to subtypes of myelodysplastic syndromes; RITALIN to treat attention deficit hyperactivity disorder; FOCALIN to prevent oncology-related disorders; and ALKERAN to treat multiple myeloma and carcinoma of the ovary. Its development stage products consist of CC-4047, which is in Phase I and Phase II clinical trials for treating disease indications, including sickle cell anemia, myelofibrosis, and multiple myeloma; CC-10004, a Phase II clinical trial product for psoriasis and psoriatic arthritis; CC-11050, a Phase I clinical trial completed product for inflammatory conditions; CC-401, a Phase I clinical trial completed product to identify kinases that regulate pathways critical in inflammation and oncology; CC-930, a Phase Ib clinicial trial completed product for fibrotic conditions; and Amrubicin, a Phase III clinical trial product for small cell lung cancer treatment. In addition, the company is researching stem cells derived from the human placenta, as well as from the umbilical cord. Celgene Corporation has strategic collaborations with Acceleron Pharma, Inc. and Agios Pharmaceuticals Inc. The company was founded in 1980 and is headquartered in Summit, New Jersey..

NeoPhotonics Corporation (NYSE:NPTN) - NeoPhotonics Corporation develops, manufactures, and sells hybrid photonic integrated optoelectronic products that transmit, receive, and switch high speed digital optical signals for communications networks. It offers high speed products, including transmitter, receiver, and switching products for 100G (gigabits per second) and optical transmission applications over distances of 2 to 2,000 kilometers; and optical components for coherent systems, including narrow linewidth tunable transmit and local oscillator lasers (NLW-ITLA), which generates ultra-pure wavelength, or color for coherent transmission, as well as integrated coherent receivers (ICRs), which decodes the phase and polarization encoded coherent signal. The company also engages in developing pluggable coherent modules that combine NLW-ITLA with ICR and with a coherent modulator; and offers 100G products for the client side and datacenter applications, as well as components, such as externally modulated lasers and high-speed drivers. In addition, it offers network products and solutions, including application-specific passive optical functionalities in modules or sub-system configurations; and products for test and measurement, instrumentation, industrial, and research applications. The company sells its products to network equipment manufacturers through a direct sales force in North America, Europe, Russia, Asia, and internationally. The company was formerly known as NanoGram Corporation and changed its name to NeoPhotonics Corporation in 2002. NeoPhotonics Corporation was founded in 1996 and is headquartered in San Jose, California..

CoreSite Realty Corporation (NYSE:COR) - CoreSite Realty Corporation engages in the ownership, acquisition, construction, and management of data centers. The data centers are specialized and secure buildings that house networking, storage, and communications technology infrastructure, including servers, storage devices, switches, routers, and fiber optic transmission equipment. These buildings provide the power, cooling, and network connectivity to operate this mission-critical equipment. The company s data centers are located in Los Angeles, the San Francisco Bay and northern Virginia areas, Chicago, Boston, New York City, and Miami. CoreSite Realty Corporation serves telecommunications carriers, content and media entertainment providers, cloud providers, enterprise customers, financial and educational institutions, and government agencies. As of December 31, 2011, its property portfolio included 12 operating data center facilities and 1 development site. The company is qualified as a real estate investment trust (REIT) under the Internal Revenue Code. As a REIT, it would not be subject to federal income taxes, if it distributes at least 90% of its REIT taxable income to its stockholders. The company was founded in 2010 and is headquartered in Denver, Colorado..

IRIDEX Corporation (NASDAQ:IRIX) - IRIDEX Corporation provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. The company offers laser consoles, such as visible (yellow) photocoagulator consoles, visible (Green) photocoagulator consoles, infrared photocoagulator consoles, micropulse enabled consoles, and multi-wavelength laser system configurations; and ophthalmic delivery devices and other products, including TxCell scanning laser delivery systems, TruFocus laser indirect ophthalmoscopes, slit lamp adapters, and operating microscope adapters. Its ophthalmic delivery devices and other products also comprise MicroPulse P3 Probe, a delivery device used in the cyclophotocoagulation procedure to treat various stages of glaucoma; EndoProbe, a fiber optic delivery device used for endophotocoagulation; G-Probe, a sterile single-use product used in procedures to treat medically and surgically uncontrolled glaucoma; DioPexy Probe, a hand-held instrument used in procedures to treat retinal tears; GreenTip Soft Tip Cannula used to visualize and access the proximity of the retina while performing a fluid air exchange during a vitrectomy procedure; and MoistAir in-line air humidifier that provides humidified air to the eye during fluid air exchange. The company serves research and teaching hospitals, government installations, surgical centers, hospitals, and office clinics. IRIDEX Corporation markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was founded in 1989 and is headquartered in Mountain View, California..

About BUYINS.NET

BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS Friction Factor - Market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements" Naked Shorts (RegSho) - Tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING Earnings - Predicts probability, price move and length of move before and after all US stock earnings reports Seasonality - Predicts probability, price move and length of move based on exact time of year for all US stocks Group Correlation - Tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups SqueezeTrigger - Massive database that tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock. Valuation - Tracks all known valuation models and applies them. GATS - Tracks and quantifies known trading strategies by backtesting, optimizing and running genetic algorithms and neural networks to ascertain best trading strategies. PatternScan - Automates tracking of every technical pattern and predicts next move in stocks. Insider - Tracks insiders trading records and determines trading performance. Trades by higher-level insiders are generally more predictive than trades by lower level insiders Events - Tracks patterns directly correlated to specific events.

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net